Developer of cancer detection and molecular diagnostic technologies. The company develops and commercializes in vitro diagnostic kits, clinical diagnostic tests for cancer screening, early-stage cancer detection, prognosis evaluation, precision cancer therapies and re-occurrence monitoring and polymerase chain reaction (PCR) kits to detect gene mutation, amplification, gene fusion, expression and polymorphisms, using in-house research laboratories and certified processes, enabling patients with individualized treatment plans.